Only 1 analyst There is only analyst covering this, so the target prices you see on most platforms including wsj , market watch etc are all referring to the same analysis. I think the only realistic ones are those with a $1 , That's the one I see from Ibkr and webull , after a reverse split, Yes $5.50 . We might be up 150 % ytd, but our sp always has been this range of 20 to 24 cents. When they announced ph1 might happen by 2019 , the sp slowly and steadily rose to 38 then the trouble with biogen ph3 held them back . This is the best time to invest in this firm no doubt, but can we trust them with their pipeline and deadlines , big NO!! But I am 100% if sure I sell now I will regret big time later but also don't want to be over optimistic.